NANOSPHERE HEA.SCIENCES (F:2CG) — Market Cap & Net Worth
Market Cap & Net Worth: NANOSPHERE HEA.SCIENCES (2CG)
NANOSPHERE HEA.SCIENCES (F:2CG) has a market capitalization of $54.06K (€46.24K) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #31104 globally and #2810 in its home market, demonstrating a -40.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NANOSPHERE HEA.SCIENCES's stock price €0.00 by its total outstanding shares 10275205 (10.28 Million).
NANOSPHERE HEA.SCIENCES Market Cap History: 2017 to 2026
NANOSPHERE HEA.SCIENCES's market capitalization history from 2017 to 2026. Data shows change from $98.99 Million to $54.06K (-59.69% CAGR).
NANOSPHERE HEA.SCIENCES Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NANOSPHERE HEA.SCIENCES's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 2CG by Market Capitalization
Companies near NANOSPHERE HEA.SCIENCES in the global market cap rankings as of May 5, 2026.
Key companies related to NANOSPHERE HEA.SCIENCES by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
NANOSPHERE HEA.SCIENCES Historical Marketcap From 2017 to 2026
Between 2017 and today, NANOSPHERE HEA.SCIENCES's market cap moved from $98.99 Million to $ 54.06K, with a yearly change of -59.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €54.06K | +800.00% |
| 2025 | €6.01K | -95.00% |
| 2024 | €120.13K | +400.00% |
| 2023 | €24.03K | -82.61% |
| 2022 | €138.15K | -89.82% |
| 2021 | €1.36 Million | -5.83% |
| 2020 | €1.44 Million | -79.59% |
| 2019 | €7.06 Million | -76.29% |
| 2018 | €29.79 Million | -69.90% |
| 2017 | €98.99 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of NANOSPHERE HEA.SCIENCES was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.06K USD |
| MoneyControl | $54.06K USD |
| MarketWatch | $54.06K USD |
| marketcap.company | $54.06K USD |
| Reuters | $54.06K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NANOSPHERE HEA.SCIENCES
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more